CD4 and neoplasm: The iC2 has a high Tumor Immune Dysfunction and Exclusion (TIDE) score, representing an immune-suppressive state characterized by elevated levels of CD8+, activated CD4+ cells, and PD-L1 expression, resulting in poor outcomes.